Literature DB >> 1967948

Inhibition of Escherichia coli glutamine synthetase by alpha- and gamma-substituted phosphinothricins.

E W Logusch1, D M Walker, J F McDonald, J E Franz, J J Villafranca, C L DiIanni, J A Colanduoni, B Li, J B Schineller.   

Abstract

We have investigated the inhibition of Escherichia coli glutamine synthetase (GS) with alpha- and gamma-substituted analogues of phosphinothricin [L-2-amino-4-(hydroxymethylphosphinyl)butanoic acid (PPT)], a naturally occurring inhibitor of GS. These compounds display inhibition of bacterial GS that is competitive vs L-glutamate, with Ki values in the low micromolar range. At concentrations greater than Ki the phosphinothricins caused time-dependent loss of enzyme activity, while dilution after enzyme inactivation resulted in recovery of enzyme activity. ATP was required for inactivation; the nonhydrolyzable ATP analogue AMP-PCP failed to support inhibition of GS by the phosphinothricins. The binding of these inhibitors to the enzyme was also characterized by measurement of changes in protein fluorescence, which provided similar inactivation rate constants k1 and k2 for the entire series of compounds. Rate constants koff for recovery were also determined by fluorescence measurement and were comparable for both PPT and the gamma-hydroxylated analogue GHPPT and significantly greater for the alpha- and gamma-alkyl-substituted compounds. Electron paramagnetic resonance spectra provided information on the interaction of the phosphinothricins with the manganese form of the enzyme in the absence of ATP, and significant binding was observed for PPT and GHPPT. 31P NMR experiments confirmed that enzyme inactivation is accompanied by hydrolysis of ATP, although phosphorylated phosphinothricins could not be detected in solution. The kinetic behavior of these compounds is consistent with a mechanism involving inhibitor phosphorylation, followed by release from the active site and simultaneous hydrolysis to form Pi and free inhibitor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1967948     DOI: 10.1021/bi00454a009

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

Review 1.  Asparagine synthetase chemotherapy.

Authors:  Nigel G J Richards; Michael S Kilberg
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

2.  An inhibitor of human asparagine synthetase suppresses proliferation of an L-asparaginase-resistant leukemia cell line.

Authors:  Jemy A Gutierrez; Yuan-Xiang Pan; Lukasz Koroniak; Jun Hiratake; Michael S Kilberg; Nigel G J Richards
Journal:  Chem Biol       Date:  2006-12

3.  Mechanistic Basis for ATP-Dependent Inhibition of Glutamine Synthetase by Tabtoxinine-β-lactam.

Authors:  Garrett J Patrick; Luting Fang; Jacob Schaefer; Sukrit Singh; Gregory R Bowman; Timothy A Wencewicz
Journal:  Biochemistry       Date:  2017-10-31       Impact factor: 3.162

4.  Inhibition of plant glutamine synthetases by substituted phosphinothricins.

Authors:  E W Logusch; D M Walker; J F McDonald; J E Franz
Journal:  Plant Physiol       Date:  1991-04       Impact factor: 8.340

5.  Synthesis, cytotoxicity, DNA binding and apoptosis of rhein-phosphonate derivatives as antitumor agents.

Authors:  Man-Yi Ye; Gui-Yang Yao; Jing-Chen Wei; Ying-Ming Pan; Zhi-Xin Liao; Heng-Shan Wang
Journal:  Int J Mol Sci       Date:  2013-04-29       Impact factor: 5.923

6.  An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: extracellular proteins as potential novel drug targets.

Authors:  G Harth; M A Horwitz
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307

7.  Initial Metabolic Step of a Novel Ethanolamine Utilization Pathway and Its Regulation in Streptomyces coelicolor M145.

Authors:  Sergii Krysenko; Arne Matthews; Nicole Okoniewski; Andreas Kulik; Melis G Girbas; Olga Tsypik; Christian Stephan Meyners; Felix Hausch; Wolfgang Wohlleben; Agnieszka Bera
Journal:  mBio       Date:  2019-05-21       Impact factor: 7.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.